BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12682161)

  • 21. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
    Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
    PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure of Staphylococcus aureus to Targocil Blocks Translocation of the Major Autolysin Atl across the Membrane, Resulting in a Significant Decrease in Autolysis.
    Tiwari KB; Gatto C; Walker S; Wilkinson BJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
    Tran N; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.
    Zheng X; Berti AD; McCrone S; Roch M; Rosato AE; Rose WE; Chen B
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.
    Renzoni A; Kelley WL; Rosato RR; Martinez MP; Roch M; Fatouraei M; Haeusser DP; Margolin W; Fenn S; Turner RD; Foster SJ; Rosato AE
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus.
    Zhao J; Cheah SE; Roberts KD; Nation RL; Thompson PE; Velkov T; Du Z; Johnson MD; Li J
    mSphere; 2016; 1(4):. PubMed ID: 27471750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin.
    Herrera M; Di Gregorio S; Fernandez S; Posse G; Mollerach M; Di Conza J
    Ann Clin Microbiol Antimicrob; 2016 Mar; 15():15. PubMed ID: 26956508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection.
    Zhao Z; Sun HQ; Wei SS; Li B; Feng Q; Zhu J; Zeng H; Zou QM; Wu C
    Sci Rep; 2015 Jul; 5():12371. PubMed ID: 26201558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.
    Gaupp R; Lei S; Reed JM; Peisker H; Boyle-Vavra S; Bayer AS; Bischoff M; Herrmann M; Daum RS; Powers R; Somerville GA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4226-38. PubMed ID: 25963986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA".
    Matsuo M; Hishinuma T; Katayama Y; Hiramatsu K
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4215-25. PubMed ID: 25941225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.
    Barber KE; Ireland CE; Bukavyn N; Rybak MJ
    Infect Dis Ther; 2014 Jun; 3(1):35-43. PubMed ID: 25134810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of vancomycin resistance in Staphylococcus aureus.
    Gardete S; Tomasz A
    J Clin Invest; 2014 Jul; 124(7):2836-40. PubMed ID: 24983424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermediate-type vancomycin resistance (VISA) in genetically-distinct Staphylococcus aureus isolates is linked to specific, reversible metabolic alterations.
    Alexander EL; Gardete S; Bar HY; Wells MT; Tomasz A; Rhee KY
    PLoS One; 2014; 9(5):e97137. PubMed ID: 24817125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocarditis and molecular imaging.
    Panizzi P; Stone JR; Nahrendorf M
    J Nucl Cardiol; 2014 Jun; 21(3):486-95. PubMed ID: 24797384
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains.
    Parker D; Planet PJ; Soong G; Narechania A; Prince A
    PLoS Pathog; 2014 Feb; 10(2):e1003951. PubMed ID: 24586160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
    Matsuo M; Cui L; Kim J; Hiramatsu K
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5843-53. PubMed ID: 24018261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of Staphylococcus aureus strains from a Paso del Norte dairy.
    Matyi SA; Dupre JM; Johnson WL; Hoyt PR; White DG; Brody T; Odenwald WF; Gustafson JE
    J Dairy Sci; 2013 Jun; 96(6):3535-42. PubMed ID: 23608491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.
    Vidaillac C; Gardete S; Tewhey R; Sakoulas G; Kaatz GW; Rose WE; Tomasz A; Rybak MJ
    J Infect Dis; 2013 Jul; 208(1):67-74. PubMed ID: 23539745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.
    Jansen A; Szekat C; Schröder W; Wolz C; Goerke C; Lee JC; Türck M; Bierbaum G
    BMC Microbiol; 2013 Mar; 13():65. PubMed ID: 23522028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.